Book a demo

Chemical intelligence powered by cypris.ai

(2R,3S)-2-(3,4-dihydroxyphenyl)-8-[(2R,3S,4S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol

(2R,3S)-2-(3,4-dihydroxyphenyl)-8-[(2R,3S,4S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol

FormulaC30H26O12
Mol. weight578.526
PubChem CID146798
InChIKeyXFZJEEAOWLFHDH-AVFWISQGSA-N
SMILESC1[C@@H]([C@H](OC2=C1C(=CC(=C2[C@H]3[C@@H]([C@H](OC4=CC(=CC(=C34)O)O)C5=CC(=C(C=C5)O)O)O)O)O)C6=CC(=C(C=C6)O)O)O
366Patents
49Research papers
55Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Suntory Holdings Ltd30
2Barry Callebaut AG10
3Kikkoman Corp9
4Nutricos Technologies SNC8
5Tianjin Institute of Industrial Biotechnology of CAS7
6Anheuser Busch InBev SA6
7Suntory Ltd5
8Henkel AG and Co KGaA4
9JNC Corp4
10KHS GmbH4

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations144
2A61PTherapeutic activity (drug indications)119
3A23LFoods and beverages (general)87
4A61QCosmetics, personal care63
5A23VFoods, foodstuffs - indexing scheme61
6C07DHeterocyclic compounds32
7C12C30
8A23FCoffee, tea; their substitutes23
9G01NInvestigating / analysing materials23
10A23C21

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Alkaloids: synthesis and pharmacology1
2Dermatology and Skin Diseases1
3Phytochemicals and Antioxidant Activities1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Nuno MateusUniversidade do Porto7
2Víctor de FreitasUniversidade do Porto6
3Kiyoshi FukuharaShowa University3
4Mirei MizunoShowa University3
5Rosa Pérez-GregórioUniversidade do Porto3
6Do Ik LeeChung-Ang University2
7Hidefumi MakabeShinshu University2
8Ikuo Nakanishi2
9Ken‐ichiro Matsumoto2
10Kwan Hee ParkChung-Ang University2

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular composition of this compound?

The compound has a molecular formula of C30H26O12 and a molecular weight of 578.526. Its InChI Key is XFZJEEAOWLFHDH-AVFWISQGSA-N.

Which organizations hold the most patents for this compound?

Suntory Holdings Ltd leads with 30 patents, followed by Barry Callebaut AG with 10 patents and Kikkoman Corp with 9 patents.

What research areas are most commonly associated with patents for this compound?

The dominant patent classification areas are A61K (pharmaceutical preparations, 144 patents), A61P (therapeutic applications, 119 patents), and A23L (food compositions, 87 patents).

Who are the most prolific academic authors publishing on this compound?

Nuno Mateus from Universidade do Porto has published 7 papers, and Víctor de Freitas also from Universidade do Porto has published 6 papers on this compound.

What does the recent patent trend suggest about research activity for this compound?

Patent filings increased significantly in recent years, with 29 patents filed in 2024 and 27 in 2023, compared to 5–8 patents per year in 2019–2020. However, academic paper publication peaked earlier, with no papers published in the last 3 years despite 366 total patents on record.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial